Hip Tendinitis Market Overview
The Hip Tendinitis Market covers diagnostic methods, therapeutic approaches, rehabilitation services, and treatment technologies used to manage inflammation and injury affecting the tendons around the hip. According to WiseGuyReports, the market was valued at approximately USD 2.0 billion in 2024 and USD 2.1 billion in 2025. It is projected to reach approximately USD 3.5 billion by 2035, expanding at a CAGR of 5.4% during the 2026–2035 forecast period. Increasing prevalence of hip injuries, an aging population, growing participation in sports and physical activities, greater awareness of treatment options, and advances in orthopedic technologies are supporting market growth.
Market Drivers
Increasing Prevalence of Hip Injuries
The rising occurrence of hip-related injuries among active individuals, athletes, and older adults is creating greater demand for diagnosis and treatment. Increased participation in sports and recreational activities is also contributing to the need for effective hip-tendinitis management solutions.
Growing Aging Population
The global aging population is supporting demand for orthopedic and musculoskeletal healthcare services. Age-related changes in joint and tendon health can increase susceptibility to hip-related conditions, encouraging greater use of diagnostic and therapeutic services.
Advancements in Treatment Technologies
Developments in minimally invasive procedures, rehabilitation technologies, imaging systems, and regenerative approaches are expanding treatment options. Improved technologies are supporting more targeted treatment and rehabilitation for patients with hip tendon injuries.
Growing Awareness of Treatment Options
Increasing awareness of hip health and available treatment approaches is encouraging patients to seek professional diagnosis and care. Greater understanding of symptoms and preventive measures can also support earlier intervention and rehabilitation.
Expansion of Physiotherapy and Rehabilitation Services
Physical therapy and guided exercise programs are becoming increasingly important components of hip-tendinitis management. The growing emphasis on conservative treatment and rehabilitation is supporting demand for physiotherapy services and related equipment.
Market Challenges
High Cost of Advanced Treatment
Advanced imaging systems, minimally invasive procedures, specialized rehabilitation equipment, and regenerative therapies can involve substantial costs. This may restrict access to certain treatment options in price-sensitive healthcare markets.
Limited Availability of Specialists
Effective diagnosis and treatment can require orthopedic specialists, physiotherapists, radiologists, and other trained healthcare professionals. Limited availability of specialists can affect access to comprehensive care in underserved areas.
Complexity of Diagnosis
Hip pain can have multiple causes, making accurate diagnosis important for determining appropriate treatment. Healthcare professionals may need to combine physical examinations with imaging technologies such as MRI, X-ray, or ultrasound.
Competition Among Treatment Approaches
The market includes physical therapy, medication, injection therapy, and surgery. Differences in clinical preference, patient condition, treatment cost, and recovery expectations can influence demand across these approaches.
Healthcare Access Disparities
Differences in healthcare infrastructure, insurance coverage, specialist availability, and diagnostic capabilities can create uneven access to hip-tendinitis treatment across regions.
Browse In-depth Market Research Report on Hip Tendinitis Market:
https://www.wiseguyreports.com/reports/hip-tendinitis-market
Market Segmentation
By Treatment Type
Physical Therapy: Physical therapy is gaining traction as patients increasingly seek conservative treatment approaches. It supports rehabilitation, strength development, flexibility, and recovery. The segment is estimated to reach approximately USD 1.2 billion by 2035.
Medication: Medication provides a non-invasive approach for managing pain and inflammation associated with hip tendinitis. The segment is projected to reach approximately USD 0.9 billion by 2035.
Surgery: Surgery represented a significant treatment category, valued at approximately USD 500 million in 2024 and projected to reach USD 800 million by 2035. It is used in cases requiring more advanced intervention.
Injection Therapy: Injection therapy provides another treatment option for managing inflammation and pain and is projected to increase from approximately USD 200 million in 2024 to USD 600 million by 2035.
By Diagnosis Method
MRI: MRI is an important diagnostic technology because of its ability to provide detailed visualization of soft tissues and tendons. It is expected to remain a leading diagnostic approach.
X-Ray: X-ray remains a fundamental diagnostic method for evaluating bone structures, joint alignment, and other conditions that may contribute to hip pain.
Ultrasound: Ultrasound provides real-time imaging and can support dynamic assessment of tendons during movement.
Physical Examination: Physical examination remains essential for initial assessment and determining whether additional imaging or diagnostic procedures are necessary.
By Age Group
Children: Although hip tendinitis is less common in children, increasing participation in sports and physical activities is contributing to demand for pediatric orthopedic evaluation.
Adults: Adults represent a major age group because of occupational activities, sports participation, lifestyle factors, and physical activity.
Elderly: The elderly population represents an important segment because age-related musculoskeletal changes can increase susceptibility to hip and tendon disorders.
By Severity Level
Mild: Mild cases are generally associated with conservative management approaches and rehabilitation.
Moderate: Moderate cases may require a combination of medication, physical therapy, injections, and additional monitoring.
Severe: Severe cases can require advanced therapies and, in selected circumstances, surgical intervention.
By Region
North America
Europe
South America
Asia Pacific
Middle East & Africa
Regional Insights
North America: North America is expected to remain the leading regional market. The region was valued at approximately USD 900 million in 2024 and is projected to reach USD 1.5 billion by 2035. Advanced healthcare infrastructure, higher orthopedic-care expenditure, and greater awareness of treatment options support regional demand.
Europe: Europe is expected to maintain steady expansion, supported by healthcare modernization, digital-health adoption, telemedicine, and established orthopedic-care infrastructure.
Asia-Pacific: Asia-Pacific is expected to experience significant growth as healthcare investment increases and awareness of hip-related conditions improves. Urbanization, lifestyle-related disorders, and expansion of advanced hospital technologies are supporting market development.
South America: South America is expected to experience moderate growth as healthcare accessibility improves and demand for orthopedic services increases.
Middle East & Africa: The Middle East and Africa are expected to show gradual growth as healthcare infrastructure expands and access to advanced diagnostic and treatment technologies improves.
Key Players
Orthofix Medical
K2M
Smith & Nephew
B. Braun Melsungen
KFx Medical
Stryker Corporation
Arthrex
Medtronic
NuVasive
Aesculap
Zimmer Biomet
Johnson & Johnson
Heraeus Medical
Wright Medical Group
DePuy Synthes
Conmed Corporation
Future Outlook
The Hip Tendinitis Market is expected to continue expanding through 2035. WiseGuyReports projects the market to increase from approximately USD 2.1 billion in 2025 to USD 3.5 billion by 2035, representing a CAGR of 5.4%. Increasing hip injuries, population aging, sports participation, and greater awareness of treatment options are expected to remain important market factors.
Treatment approaches are also evolving toward greater personalization and a combination of conservative and advanced interventions. Physical therapy, rehabilitation, minimally invasive procedures, injection therapy, and other emerging approaches are creating opportunities across different stages of disease management.
Digital healthcare is another emerging area of opportunity. Telehealth platforms can support remote consultations and follow-up, while AI-driven rehabilitation tools may enable more personalized recovery programs based on patient data.
North America is expected to remain a major market, while Asia-Pacific offers significant expansion potential as healthcare infrastructure and awareness improve. Continued investment in orthopedic technologies, physiotherapy services, advanced diagnostics, and personalized rehabilitation is expected to shape the global hip tendinitis market through 2035.
Explore additional reports to understand evolving market landscapes:
Swine Diagnostic Test Kit Market
Intravenous General Anesthetics Market
Hospital Pharmaceutical Market
